LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call

BRANCHBURG, N.J., Dec. 19 /PRNewswire-FirstCall/ -- LifeCell Corporation , today announced plans to release preliminary fourth quarter 2007 revenues and 2008 financial guidance on Monday, January 7, 2008 at 8:00 a.m. Eastern. Paul Thomas, President and Chief Executive Officer, will host a conference call at 10:00 a.m. Eastern, to discuss the Company’s fourth quarter 2007 revenues and expected financial performance for 2008.

The dial-in number for the live call is (888) 211-7292/domestic or (913) 981-4902/international. A simultaneous webcast of the call will be available via LifeCell’s website at www.lifecell.com Corporate Information - Investor Relations. The call will be archived on the Company’s website for at least 90 days.

A recording of the live-call will be available through January 12, 2008. The dial-in number to listen to the recording is (888) 203-1112 or (719) 457- 0820. The replay access code is 8968654.

About LifeCell

LifeCell develops and markets innovative biologically-based products in the emerging field of regenerative medicine for use in reconstructive, orthopedic and urogynecologic surgical procedures. LifeCell’s current marketed products include: ALLODERM(R) regenerative tissue matrix, for plastic reconstructive, general surgical, burn and periodontal procedures; CYMETRA(R) (Micronized AlloDerm(R)), a particulate form of ALLODERM(R) suitable for injection; GRAFTJACKET(R) regenerative tissue matrix, for orthopedic applications and lower extremity wounds; ALLOCRAFT(R)DBM, for bone grafting procedures; and REPLIFORM(R) tissue regeneration matrix for urogynecologic surgical procedures. The Company’s research and development initiatives include programs designed to extend the use of its current marketed regenerative tissue matrix products into new surgical applications as well as expanding its product line in the rapidly growing biosurgery market. LifeCell maintains a website at www.lifecell.com.

CONTACT: Steven T. Sobieski, Chief Financial Officer, LifeCell
Corporation, +1-908-947-1106, ssobieski@lifecell.com; or Kevin McGrath of
Cameron Associates, +1-212-245-8800, kevin@cameronassoc.com, for LifeCell
Corporation

Web site: http://www.lifecell.com/

MORE ON THIS TOPIC